...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma.
【24h】

Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma.

机译:多发性骨髓瘤中p53,p21 / Waf-1,Rb,p16和Ki67蛋白的免疫组织化学表达。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to investigate the immunohistochemical expression of the proteins p53, Waf-l/p21, Rb, p16 and Ki67 in 38 cases of multiple myelomas (MM) and 4 cases of solitary extramedullary plasmacytomas in relation to the tumor histological grade and stage. In bone marrow (BM) biopsies from MM, overexpression of p53 and p21 proteins, in comparison to plasma cell infiltrates in non-pathological bone marrow, was detected in 13 out of 38 and 21 out of 38 cases, respectively. The combined immunoexpression of p53 and p21 proteins in the 38 cases of MM showed the following patterns: a) p53+/p21+ (13 cases) b) p53-/p21+ (8 cases) and c) p53-/p21- (17 cases). Rb, p16 and Ki67 proteins were detected in tumor cells in all 38 cases and their expression increased proportionally to tumor grade. The 4 cases of solitary extramedullary plasmacytomas showed the p53+/p21+ pattern in 2 cases and the p53-/p21+ pattern in 2 cases, all of them displaying Rb, p16 and Ki67 expression in tumor cells. The pattern p53+/p21+ might represent cases with wild-type p53 able to induce p21 expression. However, in previous studies p53 mutations were reported in about 3-10% of MM, and they were strongly associated with advanced disease. Thus, in some p53+/p21+ cases associated with high p53 expression and advanced disease, p53 gene cannot be excluded and up-regulation of p21 expression may be p53- independent. P53 overexpression correlated with increased tumor grade (p < 0.005), advanced histological stage (p < 0.001) and Ki67 expression in more than 10% of tumor cells (p < 0.001). Since increase in Ki67 expression also correlated with increased tumor grade (p < 0.001) and advanced histological stage (p < 0.001), these findings suggest that impairment of the p53 growth control pathway is associated with tumor progression in MM. Thus, p53 and Ki67 immunostaining in routine BM biopsies may be helpful for the detection of MM with potentially aggressive behavior. Overexpression of p21 in MM correlated with higher Ki67 expression (p < 0.005), suggesting that the p21 function of arresting cell-cycle is impaired. Ki-67 expression in MM increased in parallel with p16 (p < 0.001) and Rb expression (p < 0.001). Rb expression could represent a growth control response which, however, might not be able to induce growth arrest in view of the parallel increase in Ki67 expression and of previous findings showing that Rb protein in MM cells is expressed mostly in its phosphorylated form.
机译:本研究的目的是研究38例多发性骨髓瘤(MM)和4例孤立性髓外浆细胞瘤中p53,Waf-1 / p21,Rb,p16和Ki67蛋白的免疫组化表达与肿瘤组织学分级的关系和舞台。在MM的骨髓活检中,与非病理性骨髓中浆细胞浸润相比,分别检测到38例中的13例和38例中的21例检测到p53和p21蛋白的过表达。 38例MM中p53和p21蛋白的联合免疫表达显示以下模式:a)p53 + / p21 +(13例)b)p53- / p21 +(8例)和c)p53- / p21-(17例) 。在所有38例病例中,在肿瘤细胞中均检测到Rb,p16和Ki67蛋白,并且它们的表达与肿瘤等级成比例地增加。孤立性髓外浆细胞瘤4例,其中2例为p53 + / p21 +型,2例为p53- / p21 +型,均在肿瘤细胞中表达Rb,p16和Ki67。模式p53 + / p21 +可能代表具有能够诱导p21表达的野生型p53的病例。然而,在先前的研究中,据报道p53突变发生在MM的3-10%左右,并且与晚期疾病密切相关。因此,在某些与高p53表达和疾病晚期相关的p53 + / p21 +病例中,不能排除p53基因,并且p21表达的上调可能与p53无关。 P53过表达与肿瘤分级增加(p <0.005),晚期组织学阶段(p <0.001)和Ki67在10%以上的肿瘤细胞中表达有关(p <0.001)。由于Ki67表达的增加也与肿瘤分级增加(p <0.001)和晚期组织学阶段(p <0.001)相关,因此这些发现表明p53生长控制途径的损伤与MM的肿瘤进展有关。因此,常规BM活检中的p53和Ki67免疫染色可能有助于检测具有潜在攻击行为的MM。 MM中p21的过度表达与更高的Ki67表达相关(p <0.005),表明p21阻滞细胞周期的功能受损。 MM中的Ki-67表达与p16(p <0.001)和Rb表达(p <0.001)平行增加。 Rb表达可能代表生长控制反应,然而,鉴于Ki67表达的平行增加和先前的发现表明MM细胞中Rb蛋白主要以其磷酸化形式表达,它可能无法诱导生长停滞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号